In lung cancer cells, lysoPC could elevate mRNA and protein expression of PI3K‐ and ERK‐signal pathways associated with 10 kinases in lysoPC‐treated cells, presenting multi‐kinase‐based molecular mechanisms (Figure S6I,J). The gene discussed is MAPK1; the disease is lung cancer.